K. Nagasato

发表

Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, S. Shirabe, 1991, Journal of the Neurological Sciences.

Cutaneous polyarteritis nodosa with necrotising vasculitis in the fascia

M. Nakashima, T. Koga, A. Kawakami, 2018 .

Anti‐cyclic citrullinated peptide antibody (anti‐CCP antibody) is present in the sera of patients with dementia of Alzheimer’s type in Asian

K. Eguchi, M. Tsujihata, K. Satoh, 2010, Acta neurologica Scandinavica.

A long surviving case of amyotrophic lateral sclerosis with atrophy of the frontal lobe: a comparison with the Mitsuyama type

I. Shimokawa, M. Tsujihata, M. Kishikawa, 2004, Acta Neuropathologica.

Interferon-alpha treatment in HTLV-I-associated myelopathy Studies of clinical and immunological aspects

S. Nagataki, M. Tsujihata, S. Shirabe, 1991, Journal of the Neurological Sciences.

Circadian rhythms of blood pressure and heart rate in patients with human T-lymphotropic virus type-I-associated myelopathy.

S. Nagataki, A. Satoh, M. Tsujihata, 1993, The Tohoku journal of experimental medicine.

Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy.

S. Nagataki, H. Watanabe, M. Tsujihata, 1995, Archives of neurology.

Antiproliferative factor against the human glioblastoma cell line T98G identified in culture supernatants of CD4+ cells from patients with HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, S. Shirabe, 1994, Journal of the Neurological Sciences.

Exon 2 containing myelin basic protein (MBP) transcripts are expressed in lesions of experimental allergic encephalomyelitis (EAE)

R. Voskuhl, M. Dubois‐Dalcq, K. Nagasato, 1997, Journal of Neuroimmunology.

ž / in lesions of experimental allergic encephalomyelitis EAE

R. Voskuhl, M. Dubois‐Dalcq, K. Nagasato, 2022 .

Active production of anti-human T-lymphotropic virus type I (HTLV-I) IgM antibody in HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, M. Motomura, 1991, Journal of Neuroimmunology.

Human T-lymphotropic virus type I(HTLV-I) associated myelopathy in Nagasaki: clinical features and treatment of 21 cases.

S. Nagataki, M. Tsujihata, M. Motomura, 1989, Japanese journal of medicine.

Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, K. Nagasato, 1994, Journal of the Neurological Sciences.

Production of granulocyte-macrophage colony stimulating factor by human T-lymphotropic virus type I-infected human glioma cells

S. Nagataki, M. Tsujihata, K. Nagasato, 1994, Journal of the Neurological Sciences.

HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid.

S. Nagataki, K. Migita, K. Eguchi, 1992, Annals of the rheumatic diseases.

Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy.

S. Nagataki, K. Eguchi, M. Tsujihata, 1992, Archives of neurology.

HTLV-I associated myelopathy in an identical twin

S. Nagataki, M. Tsujihata, M. Motomura, 1990, The Lancet.

Antiphospholipid Antibodies in Patients with Myasthenia Gravis

S. Nagataki, A. Satoh, M. Tsujihata, 1994 .

The efficacy of interferon-alpha treatment in human T-lymphotropic virus type-I-associated myelopathy.

S. Nagataki, M. Tsujihata, T. Nakamura, 1990, Japanese journal of medicine.

In vitro evidence for a dual role of tumor necrosis factor‐α in human immunodeficiency virus type 1 encephalopathy

D. Griffin, S. Wilt, H. Patton, 1995, Annals of neurology.

Locked-in syndrome and abnormal orientation of the right vertebral artery in a young man.

S. Nagataki, M. Tsujihata, T. Nakamura, 1994, Internal medicine.

Epitope spreading occurs in active but not passive EAE induced by myelin basic protein

H. McFarland, R. Voskuhl, K. Nagasato, 1996, Journal of Neuroimmunology.

Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution

Y. Itoyama, K. Fujihara, T. Sato, 2007, Journal of Neurology.

Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease

H. Sasaki, Tadahiro Nakamura, K. Satoh, 2014, Journal of NeuroVirology.

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial

H. Sasaki, K. Satoh, Hideki Nakamura, 2013, BMC Medicine.

Heparin treatment in patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy: A preliminary study

S. Nagataki, K. Nagasato, Tatsufumi Nakamura, 1993, Journal of the Neurological Sciences.

Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.

S. Nagataki, M. Tsujihata, M. Motomura, 1990, Current studies in hematology and blood transfusion.

Anhedonia in Japanese patients with Parkinson's disease: Analysis using the Snaith–Hamilton Pleasure Scale

T. Taniwaki, Jouchi Nakajima, H. Aizawa, 2012, Clinical Neurology and Neurosurgery.

LONG-TERM FOLLOW-UP OF IMMUNOMODULATION IN TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY

S. Nagataki, M. Tsujihata, H. Matsuo, 1989, The Lancet.

Antiphospholipid Antibodies in Patients with Myasthenia Gravis

S. Nagataki, A. Satoh, M. Tsujihata, 1994 .